using the electrodes.
5. The neuronal membrane potential experienced a minimal change when the resting
membrane potential of -70mV was altered to -60mV. However, a significant alteration in
the membrane potential was observed when the voltage was further modified to -5mV.
6. The inclusion of Lidocaine in the buffer solution, coupled with a voltage measurement
of -5mV, demonstrated that Lidocaine effectively prevents the opening of sodium
channels. Consequently, this inhibition of sodium channels should lead to a diminished
perception of pain.
7. Subsequently, the buffer solution was modified to incorporate the drug Rebine while
maintaining a voltage of -5mV. This experiment revealed that Rebine does not appear to
have an impact on sodium channels, as the resulting graph closely resembled the control
graph. Following this, the buffer solution was further modified to include capsaicin and
Rebine, with the voltage remaining at -5mV.
8. Through the execution of a voltage test using the combination of Rebine and capsaicin
in the buffer solution, it was determined that this combination does not inhibit action
potential. It was observed that Rebine alone does not seem to activate sodium channels,
and its effectiveness relies on the channels already being open. The Rebine/capsaicin
combination allows for an increase in membrane voltage without triggering an action
potential.
9. Subsequently, the effects of Lidocaine and Rebine were examined on a live animal
specimen.
10. Following the injection of a control solution into the live specimen, the reflex time to
heat-induced pain was measured and recorded. Subsequently, the specimen was injected
with capsaicin and tested for reflex time to pain. The reflex time was slightly shorter,
potentially indicating that the specimen was closer to its pain threshold due to the
capsaicin injection.
11. Next, the specimen was injected with Lidocaine and tested for pain reflex time. The
results indicated a slower reflex time, as Lidocaine inhibits the activation of nociceptors.
When a mixture of Lidocaine and capsaicin was administered, a similar slow reflex time
was observed, albeit marginally faster.
12. Subsequently, the specimen undergoes an injection of Rebine and undergoes a reflex
test to assess its response to pain, yielding outcomes comparable to those observed with
the control solution. Following this, a combination of Rebine and capsaicin is administered
via injection, and the specimen's pain reflex is evaluated. The outcome reveals a
marginally swifter reaction compared to the combination of Lidocaine and capsaicin.
13. The results of this examination indicate that Lidocaine has the ability to alleviate pain,
regardless of the presence of capsaicin, whereas Rebine necessitates the presence of
capsaicin in order to produce its pain-relieving effects.
7
Copyright Labster ApS 2021
All Rights Reserved